The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

Embolism from the heart or the thoracic aorta often leads to clinically significant morbidity
and mortality due to transient ischemic attack, stroke or occlusion of peripheral arteries …

Background The options for secondary prevention of cryptogenic embolism in patients with
patent foramen ovale are administration of antithrombotic medications or percutaneous …

Venous thromboembolism (VTE) is a serious complication that is frequently encountered in
medical and surgical practice. Approximately 2 million people each year will suffer from a …

Background Patent foramen ovale (PFO) is a vestigial congenital cardiovascular structure
present in around 25% of adults. In most cases, PFO is entirely benign and requires no …

Objective: To examine the association between patent foramen ovale (PFO) and atrial septal
aneurysm (ASA) and stroke. Method:—Data from case-control studies that examined the …

Background Patent foramen ovale and atrial septal aneurysm have been identified as
potential risk factors for stroke, but information about their effect on the risk of recurrent …

Background—Patent foramen ovale (PFO) is associated with stroke, but there are no
randomized studies to evaluate the efficacy of antithrombotic therapies. Methods and …

Paradoxical embolism is an important clinical entity among patients with venous
thromboembolism in the presence of intracardiac or pulmonary shunts. The clinical …

tion by TCD does not necessarily imply the presence of a PFO. Any right-to-left shunt such
as that resulting from ventricular septal defect or intrapulmonary shunt may result in the …